Company Filing History:
1 out of 532 
1 out of 265 
1 out of 60 
Years Active: 2012-2016
Title: Eric Lader: Innovator in Nucleic Acid Technologies
Introduction
Eric Lader is a notable inventor based in Boyds, MD (US), recognized for his contributions to the field of nucleic acid technologies. With a total of 3 patents, Lader has made significant advancements that enhance the efficacy and safety of small interfering nucleic acids (siNAs).
Latest Patents
One of Lader's latest patents is titled "Modified siNA." This invention pertains to the use of at least one abasic modification within the first 8 nucleotide positions of the 5' region of the antisense strand of a small interfering nucleic acid (siNA) molecule for reducing off-target effects. The patent provides suitable modified siNAs, compositions, methods for producing respective siNAs, and kits comprising these siNAs. Another significant patent is "Apoptosis Inducing Positive Control for Expression Modulation Experiments." This invention outlines a method for performing expression modulating analysis or assays, wherein an apoptosis-inducing expression modulating compound targeting a repetitive element present in the untranslated region, particularly the 3' UTRs of protein-coding gene transcripts, is introduced into cells to induce apoptosis as a positive control. This patent also includes suitable kits and compositions.
Career Highlights
Throughout his career, Eric Lader has worked with prominent companies such as Applied Biosystems, LLC and Qiagen GmbH. His experience in these organizations has contributed to his expertise in the development of innovative nucleic acid technologies.
Collaborations
Lader has collaborated with notable professionals in his field, including Peter Hahn and Wolfgang Bielke. These collaborations have likely enriched his research and development efforts.
Conclusion
Eric Lader's work in the field of nucleic acid technologies demonstrates his commitment to innovation and improvement in scientific methodologies. His patents reflect a deep understanding of the complexities of gene expression and the potential for enhanced therapeutic applications.